Australia markets closed

Alaunos Therapeutics, Inc. (TCRT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.0800-0.0700 (-6.09%)
At close: 04:00PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
6,062
39,058
76,054
115,069
-
Total cash
6,062
39,058
76,054
115,069
-
Net receivables
1
4
1,111
4,665
-
Other current assets
2,198
799
1,666
10,855
-
Total current assets
8,261
53,799
78,831
130,589
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
15
20,403
22,774
19,843
-
Accumulated depreciation
-13
-9,807
-7,413
-4,962
-
Net property, plant and equipment
2
10,596
15,361
14,881
-
Other long-term assets
-
500
631
745
110
Total non-current assets
2
11,138
16,034
15,756
-
Total assets
8,263
64,937
94,865
146,345
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
16,765
7,868
-
-
Accounts payable
616
1,389
1,368
960
-
Accrued liabilities
1,297
4,294
4,154
13,275
-
Total current liabilities
1,956
24,166
16,041
18,368
-
Non-current liabilities
Long-term debt
-
-
16,250
-
-
Other long-term liabilities
-
28
-1
-
-
Total non-current liabilities
0
2,216
20,767
3,995
-
Total liabilities
1,956
26,382
36,808
22,363
-
Stockholders' equity
Common stock
16
16
216
215
-
Retained earnings
-915,767
-880,627
-842,852
-764,101
-
Total stockholders' equity
6,307
38,555
58,057
123,982
-
Total liabilities and stockholders' equity
8,263
64,937
94,865
146,345
-